Press Releases bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
2.37 ^USD	-1.66%		-14.75%	+61.17%

01/04	BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
20/03	BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth	24/04	BU
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening	09/04	BU
BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results	01/04	BU
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	11/03	AQ
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	08/03	PR
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	08/03	BU
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	06/03	PR
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	06/03	BU
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath Lung	06/03	AQ
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung	05/03	BU
BioAffinity Technologies News Update	21/02	BU
Medical Director of Pennsylvania's Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies Medical and Scientific Advisory Board and Incorporates CyPath Lung into Medical Practice	07/02	AQ
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice	06/02	BU
BioAffinity Technologies In The News	30/01	BU
BioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer	23/01	BU
BioAffinity Technologies In the News	08/01	BU
BioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors	05/12	BU
CMS Posts Final Payment Determination for bioAffinity Technologies CyPath Lung Effective January 2024	01/12	AQ
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024	30/11	BU
BioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post	28/11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Press Releases

Filters